                     Notes from Meeting with PhRMA Members
                                       
                                       
Attended by:
Eli Lilly & Co.	Neil Parke

Glaxo Smith Kline:	Doug Finan

Merck:			Jim Jahnke

Pfizer:			Elizabeth Auda

EPA Staff:	Tracy Atagi, Chichang Chen, Kristin Fitzgerald, Richard Huggins

Date:			May 1, 2013


EPA met with representatives of Eli Lilly & Co, Glaxo Smith Kline, Merck and Pfizer.  Although all are members of PhRMA, each was representing their individual companies, not PhRMA.

The companies inquired about the progress of the pharmaceuticals proposed rule.  They raised the following issues that they hope the proposed rule will address:

   1. P-listed hazardous waste pharmaceuticals
   2. Household hazardous waste/take-back programs
   3. Controlled substances/coordinate with DEA

